LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of…
Congratulations @KordastiL, and @kazemianlab, @LionakisLab, @CWobus, Kemper lab, @OlsonLabPU et al, on publishing t… https://t.co/s5wQUaDpwW
LifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging…
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge…
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…
LifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…
LifeArc and Cleveland Clinic collaborate to advance early stage research towards patients
LifeArc to fund two post-doctoral fellowships focused on drug discovery In November 2020, LifeArc initiated a new…
KQ Labs Accelerator welcomes 10 innovative start-ups
London, UK - KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick…
UK DRI appoints LifeArc to support translation of discoveries into treatments
LifeArc has been appointed by the UK Dementia Research Institute (UK DRI) to provide expertise to accelerate…
LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics
Funding to help drive the development of new cancer therapies